Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis
PolandStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
BulgariaStudy on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
BulgariaTitle: Study of Solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety
BelgiumStudy on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis
BelgiumStudy on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Rituximab and Cyclophosphamide for Treating ANCA-Associated Vasculitis in Patients Seeking Remission
PolandStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
AustriaStudy on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis
ItalyStudy on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
BelgiumStudy on the Effects of PF-07275315 and PF-07264660 for Adults with Moderate to Severe Atopic Dermatitis
GermanyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
